Viking Therapeutics, Inc. (VKTX)
|52 Week Range||2.535-25.72|
|1y Target Est||-|
|DCF Unlevered||VKTX DCF ->|
|DCF Levered||VKTX LDCF ->|
|Debt / Equity||0.37%||Neutral|
Upgrades & Downgrades
Latest VKTX news
Viking Therapeutics to Participate at Upcoming Investor Conferences
7 September 2023
SAN DIEGO , Sept. 7, 2023 /PRNewswire/ -- Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic an...
The 7 Most Undervalued Healthcare Stocks to Buy Now: August 2023
16 August 2023
Investors always hope to buy low and sell high. In order to do so, it's necessary to identify stocks that are undervalued.
Viking Therapeutics stock gets boost from positive news that obesity drugs reduced risk of heart att...
9 August 2023
The stock of biotech Viking Therapeutics Inc. was up 4% Wednesday to extend its week-to-date gains to 13%, after positive news on Novo Nordisk's obesity drugs reducing the risk of cardio events ignite...
Why Eli Lilly, Novo Nordisk, and Viking Therapeutics Are On Fire Today
8 August 2023
Novo Nordisk's popular weight loss drug significantly reduced the risk of heart attack or stroke in a late-stage trial. These data bode well for the obesity drug category at large.
2 Magnificient Growth Stocks I'm Buying in August
2 August 2023
Growth stocks have returned to form this year. Roivant Sciences and Viking Therapeutics are two growth plays that should interest risk-tolerant investors.
3 Top Biotech Stocks Defying the Bear Market
13 July 2023
Vertex Pharmaceuticals' strong pipeline is positioning the company for the future. Viking Therapeutics' stock is soaring as the market anticipates its candidate drugs hitting the marketplace.
2 Hot Stocks Up 30% This Year That Wall Street Thinks Can Still Go Higher
12 July 2023
Hims & Hers has a booming telemedicine business that could grow by 57% this year. Viking Therapeutics has a promising pipeline that features a couple of potential blockbuster drugs.
The 3 Best Momentum Stocks to Buy in July
7 July 2023
Momentum stocks offer investors the opportunity to capitalize on strong and continued upward price changes. At the same time, it is an inherently and undeniably risky trading method.
The 3 Most Undervalued Biotech Stocks to Buy Now: June 2023
29 June 2023
Now is a great time to accumulate top undervalued biotech stocks. For one, the sector is recession-proof.